Man Killed, Woman Injured in Crash on Balboa Boulevard

Posted on March 4, 2020March 4, 2020 by Staff Writer

Car Hits Palm Tree, Splits in Half in Fatal Newport Beach Accident

Newport Beach, CA (March 3, 2020) – A driver was killed and his passenger was injured in a crash during a police chase in Newport Beach. The fatal accident occurred on the morning of March 3 on Balboa Boulevard.

A Mercedes-Benz AMG involved in a police chase was speeding at 100 mph when it failed to negotiate a turn on Balboa Boulevard, near 24^th Street. The driver lost control and hit a palm tree. The Mercedes split in half, scattering debris all over the road.

The driver, a 29-year-old man, died at the accident scene. A female passenger was hospitalized with major injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Newport Beach

#92663

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

What can we do for you?

Answer your legal question.

Provide a Free Case Evaluation.

Schedule an appointment.

Why Choose Us?

Available 24/7

Trusted Since 1990

Local to You

Recovered $350,000,000

5 Star Reviews

Free Case Evaluation

VIP Service

No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.